From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective

被引:1
|
作者
Rester, Ulrich [1 ]
机构
[1] Bayer HealthCare, Global Drug Discovery, Lead Generat & Optimizat, Med Chem, D-42096 Elberfeld, Germany
关键词
drug design; ITC; NMR; virtual screening; x-ray crystallography;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug discovery and development is an interdisciplinary, expensive and time-consuming process. Scientific advancements during the past two decades have altered the way pharmaceutical research produces novel bio-active molecules. Advances in computational techniques and hardware solutions have enabled in silico methods, and in particular virtual screening, to speed up modern lead identification and lead optimization. Recent successes have proven the power of combining virtual screening with complementary and synergistic biophysical methods, such as X-ray crystallography, NMR spectroscopy and isothermal titration calorimetry (ITC). This review addresses key issues, challenges and recent improvements of virtual screening methods and strategies. Examples highlighting the impact of an ntegrated virtual screening and biophysical characterization platform in the lead identification and optimization process are presented and discussed.
引用
下载
收藏
页码:559 / 568
页数:10
相关论文
共 50 条
  • [21] Virtual and augmented reality applications in medicinal chemistry
    Grieco, Paolo
    FUTURE MEDICINAL CHEMISTRY, 2022, 14 (20) : 1417 - 1419
  • [22] Lead discovery and optimization for IspD
    Seet, Michael
    Witschel, Matthias C.
    Hoeffken, Wolfgang
    Parra, Liliana
    Mietzner, Thomas
    Thater, Frank
    Niggeweg, Ricarda
    Roehl, Franz
    Illarionov, Boris
    Rohdich, Felix
    Kaiser, Johannes
    Fischer, Markus
    Bacher, Adelbert
    Diederich, Francois
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [23] Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for Trypanosoma brucei Inhibitors
    Singh, Baljinder
    Diaz-Gonzalez, Rosario
    Ceballos-Perez, Gloria
    Rojas-Barros, Domingo I.
    Gunaganti, Naresh
    Gillingwater, Kirsten
    Santos Martinez-Martinez, Maria
    Manzano, Pilar
    Navarro, Miguel
    Pollastri, Michael P.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (17) : 9912 - 9927
  • [24] Lead optimization attrition analysis (LOAA): a novel and general methodology for medicinal chemistry
    Munson, Mark
    Lieberman, Harvey
    Tserlin, Elina
    Rocnik, Jennifer
    Ge, Jie
    Fitzgerald, Maria
    Patel, Vinod
    Garcia-Echeverria, Carlos
    DRUG DISCOVERY TODAY, 2015, 20 (08) : 978 - 987
  • [25] MEDICINAL CHEMISTRY New lead for pain treatment
    Reisman, Sarah E.
    NATURE, 2011, 473 (7348) : 458 - 459
  • [26] Drug discovery: From computational screening to synthesis of lead compounds
    Brown, Joseph
    Sirois, John
    DeBoef, Brenton
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [27] Thermodynamics guided lead discovery and optimization
    Ferenczy, Gyoergy G.
    Keserue, Gyoergy M.
    DRUG DISCOVERY TODAY, 2010, 15 (21-22) : 919 - 932
  • [28] Thermodynamics guided lead discovery and optimization
    Keseru, Gyorgy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [29] Efficient Drug Lead Discovery and Optimization
    Jorgensen, William L.
    ACCOUNTS OF CHEMICAL RESEARCH, 2009, 42 (06) : 724 - 733
  • [30] Computer lead optimization boosters for medicinal chemists
    Gastreich, Marcus
    Detering, Carsten
    Lemmen, Christian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243